31.12
price down icon3.11%   -1.00
after-market Handel nachbörslich: 31.20 0.08 +0.26%
loading
Schlusskurs vom Vortag:
$32.12
Offen:
$32.04
24-Stunden-Volumen:
5.68M
Relative Volume:
0.53
Marktkapitalisierung:
$12.42B
Einnahmen:
$5.06B
Nettoeinkommen (Verlust:
$-2.22B
KGV:
-5.3471
EPS:
-5.82
Netto-Cashflow:
$-3.96B
1W Leistung:
-4.72%
1M Leistung:
+0.10%
6M Leistung:
-52.67%
1J Leistung:
-70.80%
1-Tages-Spanne:
Value
$31.02
$32.50
1-Wochen-Bereich:
Value
$31.02
$34.87
52-Wochen-Spanne:
Value
$29.25
$170.47

Moderna Inc Stock (MRNA) Company Profile

Name
Firmenname
Moderna Inc
Name
Telefon
(617) 714-6500
Name
Adresse
325 BINNEY STREET, CAMBRIDGE
Name
Mitarbeiter
0
Name
Twitter
@moderna_tx
Name
Nächster Verdiensttermin
2025-02-14
Name
Neueste SEC-Einreichungen
Name
MRNA's Discussions on Twitter

Vergleichen Sie MRNA mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
MRNA
Moderna Inc
31.12 12.42B 5.06B -2.22B -3.96B -5.82
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
492.69 131.41B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
637.36 72.26B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
589.15 35.93B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
268.46 34.75B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
ONC
Beigene Ltd Adr
267.39 28.24B 3.81B -644.79M -669.77M -6.24

Moderna Inc Stock (MRNA) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-03-13 Eingeleitet Citigroup Neutral
2025-02-18 Herabstufung Barclays Overweight → Equal Weight
2025-01-29 Herabstufung Goldman Buy → Neutral
2024-12-18 Herabstufung Argus Buy → Hold
2024-12-10 Fortgesetzt BofA Securities Underperform
2024-11-19 Eingeleitet Berenberg Hold
2024-11-18 Hochstufung HSBC Securities Hold → Buy
2024-11-15 Eingeleitet Wolfe Research Underperform
2024-10-17 Eingeleitet Bernstein Mkt Perform
2024-09-13 Herabstufung JP Morgan Neutral → Underweight
2024-09-13 Herabstufung Jefferies Buy → Hold
2024-09-13 Herabstufung Oppenheimer Outperform → Perform
2024-08-28 Hochstufung HSBC Securities Reduce → Hold
2024-08-07 Hochstufung Deutsche Bank Sell → Hold
2024-08-05 Herabstufung RBC Capital Mkts Outperform → Sector Perform
2024-02-26 Herabstufung HSBC Securities Hold → Reduce
2024-01-02 Hochstufung Oppenheimer Perform → Outperform
2023-11-29 Eingeleitet Canaccord Genuity Hold
2023-11-03 Hochstufung HSBC Securities Reduce → Hold
2023-11-02 Herabstufung Deutsche Bank Hold → Sell
2023-08-04 Herabstufung TD Cowen Outperform → Market Perform
2023-08-03 Herabstufung Deutsche Bank Buy → Hold
2023-07-24 Eingeleitet William Blair Mkt Perform
2023-07-14 Eingeleitet HSBC Securities Reduce
2023-06-26 Hochstufung UBS Neutral → Buy
2023-04-26 Eingeleitet Guggenheim Neutral
2023-03-13 Hochstufung TD Cowen Market Perform → Outperform
2023-03-02 Eingeleitet RBC Capital Mkts Outperform
2023-02-24 Herabstufung SVB Securities Market Perform → Underperform
2022-12-19 Hochstufung Jefferies Hold → Buy
2022-12-14 Herabstufung Chardan Capital Markets Buy → Neutral
2022-10-21 Hochstufung SVB Leerink Underperform → Mkt Perform
2022-09-08 Hochstufung Deutsche Bank Hold → Buy
2022-02-01 Hochstufung Redburn Sell → Neutral
2022-01-26 Hochstufung Deutsche Bank Sell → Hold
2022-01-21 Hochstufung BofA Securities Underperform → Neutral
2022-01-21 Eingeleitet UBS Neutral
2021-12-07 Eingeleitet Cowen Market Perform
2021-11-09 Eingeleitet Wolfe Research Outperform
2021-10-22 Eingeleitet Deutsche Bank Sell
2021-10-15 Hochstufung Piper Sandler Neutral → Overweight
2021-08-06 Herabstufung Oppenheimer Outperform → Perform
2021-08-06 Herabstufung Piper Sandler Overweight → Neutral
2021-07-15 Bestätigt Jefferies Hold
2021-02-01 Herabstufung BofA Securities Neutral → Underperform
2020-12-16 Herabstufung Jefferies Buy → Hold
2020-12-16 Herabstufung Morgan Stanley Overweight → Equal-Weight
2020-12-09 Herabstufung Needham Buy → Hold
2020-11-23 Eingeleitet Wells Fargo Equal Weight
2020-11-17 Herabstufung BMO Capital Markets Outperform → Market Perform
2020-09-08 Herabstufung SVB Leerink Mkt Perform → Underperform
2020-07-23 Eingeleitet SVB Leerink Mkt Perform
2020-07-20 Herabstufung JP Morgan Overweight → Neutral
2020-07-13 Eingeleitet Jefferies Buy
2020-06-30 Eingeleitet Argus Buy
2020-06-08 Eingeleitet Barclays Overweight
2020-04-30 Eingeleitet BMO Capital Markets Outperform
2020-03-05 Herabstufung BofA/Merrill Buy → Neutral
2019-12-03 Fortgesetzt BofA/Merrill Buy
2019-10-25 Eingeleitet ROTH Capital Buy
2019-04-05 Eingeleitet Chardan Capital Markets Buy
Alle ansehen

Moderna Inc Aktie (MRNA) Neueste Nachrichten

pulisher
Mar 29, 2025

Motley Fool Wealth Management LLC Cuts Stake in Moderna, Inc. (NASDAQ:MRNA) - MarketBeat

Mar 29, 2025
pulisher
Mar 29, 2025

Jim Cramer Slams Moderna, Inc. (MRNA) as One of the Year’s Biggest Disappointments - Insider Monkey

Mar 29, 2025
pulisher
Mar 29, 2025

Teacher Retirement System of Texas Purchases 12,651 Shares of Moderna, Inc. (NASDAQ:MRNA) - MarketBeat

Mar 29, 2025
pulisher
Mar 29, 2025

Mitsubishi UFJ Trust & Banking Corp Has $25.79 Million Stock Position in Moderna, Inc. (NASDAQ:MRNA) - MarketBeat

Mar 29, 2025
pulisher
Mar 28, 2025

KLP Kapitalforvaltning AS Invests $4.44 Million in Moderna, Inc. (NASDAQ:MRNA) - MarketBeat

Mar 28, 2025
pulisher
Mar 28, 2025

Vanguard Group Inc. Boosts Stock Position in Moderna, Inc. (NASDAQ:MRNA) - MarketBeat

Mar 28, 2025
pulisher
Mar 28, 2025

Moderna, Inc. (NASDAQ:MRNA) Stake Lowered by Corient Private Wealth LLC - MarketBeat

Mar 28, 2025
pulisher
Mar 28, 2025

Royal London Asset Management Ltd. Sells 178,991 Shares of Moderna, Inc. (NASDAQ:MRNA) - MarketBeat

Mar 28, 2025
pulisher
Mar 27, 2025

Is Moderna Stock A Sell With RFK Jr. Reportedly Eyeing Funds? - Investor's Business Daily

Mar 27, 2025
pulisher
Mar 27, 2025

Jim Cramer: Moderna (MRNA) Blew It – But Their Cash Pile Could Save Them! - Insider Monkey

Mar 27, 2025
pulisher
Mar 27, 2025

Moderna's Options Frenzy: What You Need to Know - Benzinga

Mar 27, 2025
pulisher
Mar 27, 2025

Moderna, Inc. (MRNA): Among Stocks To Trade Without Tariffs And Interest Rate Fears - Insider Monkey

Mar 27, 2025
pulisher
Mar 27, 2025

Trump administration at ‘war’ with mRNA technology: scientists alarmed vaccine skeptics could kill research - Inkl

Mar 27, 2025
pulisher
Mar 26, 2025

As Vaccine Skepticism Mounts, Moderna’s Business Grows More Precarious - Barron's

Mar 26, 2025
pulisher
Mar 26, 2025

Moderna chief brand officer Kate Cronin exits pharma giant - MM+M Online

Mar 26, 2025
pulisher
Mar 26, 2025

Moderna, Novavax Shares Are Sliding Wednesday: What's Going On?Moderna (NASDAQ:MRNA) - Benzinga

Mar 26, 2025
pulisher
Mar 26, 2025

Moderna, Novavax, and Pfizer shares fall amid U.S. vaccine fund cuts - Investing.com

Mar 26, 2025
pulisher
Mar 26, 2025

Moderna, Inc. (NASDAQ:MRNA) Given Average Rating of "Hold" by Analysts - MarketBeat

Mar 26, 2025
pulisher
Mar 26, 2025

JPMorgan Chase & Co. Lowers Moderna (NASDAQ:MRNA) Price Target to $33.00 - MarketBeat

Mar 26, 2025
pulisher
Mar 26, 2025

Northwest & Ethical Investments L.P. Grows Stock Holdings in Moderna, Inc. (NASDAQ:MRNA) - MarketBeat

Mar 26, 2025
pulisher
Mar 25, 2025

Is Moderna, Inc. (MRNA) a Promising Biotech Stock According to Wall Street Analysts - Insider Monkey

Mar 25, 2025
pulisher
Mar 25, 2025

Raymond James Financial Inc. Purchases New Holdings in Moderna, Inc. (NASDAQ:MRNA) - MarketBeat

Mar 25, 2025
pulisher
Mar 24, 2025

USPTO Finds Claims of Two of Moderna’s mRNA Patents Unpatentable: What’s Next in the Vaccine Wars? - Crowell & Moring LLP

Mar 24, 2025
pulisher
Mar 24, 2025

Moderna, Inc. (MRNA): Among Stocks with Potential to Explode in 2025 - Insider Monkey

Mar 24, 2025
pulisher
Mar 24, 2025

Q4 Rundown: Moderna (NASDAQ:MRNA) Vs Other Therapeutics Stocks - Yahoo Finance

Mar 24, 2025
pulisher
Mar 24, 2025

Avantax Advisory Services Inc. Invests $483,000 in Moderna, Inc. (NASDAQ:MRNA) - MarketBeat

Mar 24, 2025
pulisher
Mar 24, 2025

Privium Fund Management B.V. Increases Stock Holdings in Moderna, Inc. (NASDAQ:MRNA) - MarketBeat

Mar 24, 2025
pulisher
Mar 23, 2025

mRNA Patent Wars Update: The Plot Thickens with Key Rulings Expected in 2025 - IPWatchdog.com

Mar 23, 2025
pulisher
Mar 22, 2025

Moderna price target lowered to $33 from $40 at JPMorgan - Yahoo Finance

Mar 22, 2025
pulisher
Mar 22, 2025

Buying These Dirt-Cheap Stocks Could Be a Brilliant Move - The Motley Fool

Mar 22, 2025
pulisher
Mar 21, 2025

Wealthfront Advisers LLC Lowers Holdings in Moderna, Inc. (NASDAQ:MRNA) - MarketBeat

Mar 21, 2025
pulisher
Mar 21, 2025

Moderna, Inc. (MRNA) Is a Trending Stock: Facts to Know Before Betting on It - Yahoo Finance

Mar 21, 2025
pulisher
Mar 21, 2025

JPMorgan Cuts Price Target on Moderna to $33 From $40, Maintains Underweight Rating - Marketscreener.com

Mar 21, 2025
pulisher
Mar 21, 2025

Proficio Capital Partners LLC Raises Holdings in Moderna, Inc. (NASDAQ:MRNA) - MarketBeat

Mar 21, 2025
pulisher
Mar 20, 2025

Moderna, Inc. (NASDAQ:MRNA) Shares Sold by Swiss National Bank - MarketBeat

Mar 20, 2025
pulisher
Mar 20, 2025

Skandinaviska Enskilda Banken AB publ Decreases Position in Moderna, Inc. (NASDAQ:MRNA) - MarketBeat

Mar 20, 2025
pulisher
Mar 20, 2025

U.S. to spend $100M to develop bird flu vaccines, drugs (MRNA) (MRNA:NASDAQ) - Seeking Alpha

Mar 20, 2025
pulisher
Mar 20, 2025

Moderna's Options: A Look at What the Big Money is Thinking - Benzinga

Mar 20, 2025
pulisher
Mar 20, 2025

4 Things You Need to Know if You Buy Moderna Stock Today - Nasdaq

Mar 20, 2025
pulisher
Mar 20, 2025

Intact Investment Management Inc. Invests $420,000 in Moderna, Inc. (NASDAQ:MRNA) - MarketBeat

Mar 20, 2025
pulisher
Mar 19, 2025

Victory Capital Management Inc. Sells 168,512 Shares of Moderna, Inc. (NASDAQ:MRNA) - MarketBeat

Mar 19, 2025
pulisher
Mar 19, 2025

Moderna. Why Anti-Covid19 Juggernaut Goes 'The Bloodmachine' for NASDAQ:MRNA by PandorraResearch - TradingView

Mar 19, 2025

Finanzdaten der Moderna Inc-Aktie (MRNA)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$77.99
price up icon 0.39%
$306.97
price down icon 0.34%
$31.37
price down icon 0.88%
$20.32
price down icon 1.36%
$94.95
price down icon 0.47%
biotechnology ONC
$267.39
price up icon 1.82%
Kapitalisierung:     |  Volumen (24h):